Amorolfine is a broad-spectrum antifungal agent primarily used topically to treat superficial fungal infections, including onychomycosis (nail fungus) and skin dermatophytoses. It belongs to the morpholine class of antifungals and works by inhibiting fungal sterol biosynthesis, disrupting cell membrane integrity, and causing fungal cell death. Developed in the late 20th century, amorolfine offered an alternative to earlier antifungals with improved efficacy against both dermatophytes and yeasts and a favorable safety profile. Available in formulations such as nail lacquers and creams, it allows localized treatment with minimal systemic absorption, making it a mainstay in dermatology for managing chronic or resistant superficial fungal infections.
BRAND NAMES
Loceryl – commonly used medicated nail lacquer for fungal nail infections (onychomycosis).
Curanail – topical nail lacquer used for treating fungal infections of the nails.
Locetar – another brand formulation used for similar antifungal purposes.
MECHANISM OF ACTION
Amorolfine is a morpholine antifungal agent that works by interfering with the synthesis of ergosterol, an essential component of fungal cell membranes. It inhibits key enzymes, specifically Δ14-reductase and Δ7–Δ8-isomerase, which are involved in the ergosterol biosynthesis pathway. This inhibition leads to depletion of ergosterol and accumulation of abnormal sterols within the fungal cell membrane. As a result, the membrane structure becomes disrupted and more permeable, causing leakage of vital cellular contents and ultimately leading to fungal cell death.
PHARMACOKINETICS
Absorption
Amorolfine is applied topically and penetrates the nail or skin to reach the site of infection. Its systemic absorption is minimal, with very little entering the bloodstream, allowing effective local action with low risk of systemic effects.
Distribution
Amorolfine is mainly distributed locally at the site of application, such as the nail plate and surrounding tissues. It achieves high concentrations in keratin-rich areas, with negligible distribution into the systemic circulation due to minimal absorption.
Metabolism
Amorolfine undergoes minimal systemic metabolism because only a very small amount is absorbed into the bloodstream. Any absorbed portion is slowly metabolized in the body, but this process is not clinically significant due to its primarily local action.
Elimination
Amorolfine is eliminated mainly after minimal systemic absorption. Any small amount that enters the bloodstream is metabolized and its metabolites are excreted primarily through urine. However, since the drug acts locally and systemic levels are very low, elimination is not clinically significant.
PHARMACODYNAMICS
Amorolfine is a morpholine antifungal agent that exerts its effect by inhibiting ergosterol synthesis in fungal cell membranes. By blocking the enzymes Δ14-reductase and Δ7–Δ8-isomerase, it disrupts the normal sterol composition, leading to accumulation of abnormal sterols and depletion of ergosterol. This disruption increases membrane permeability, causing leakage of cellular contents and ultimately fungal cell death. Amorolfine is fungicidal against dermatophytes, yeasts, and molds, and it demonstrates enhanced efficacy when used consistently in topical formulations for nail and skin infections.
ADMINISTRATION
Amorolfine is administered topically, most commonly as a medicated nail lacquer or cream. For nail infections, the lacquer is usually applied once or twice weekly to the affected nails after cleaning and filing. For skin infections, the cream is applied once or twice daily to the affected area. Consistent and prolonged use is essential for effective treatment, as fungal infections, especially of the nails, require several months of therapy to fully resolve.
DOSAGE AND STRENGTH
Amorolfine is commonly available as a 5% nail lacquer for treating fungal nail infections.
For skin infections, it is available as a 0.25%–0.5% cream depending on the formulation.
Nail lacquer: Apply once or twice weekly to the affected nails after cleaning and filing.
Cream: Apply once or twice daily to the affected skin area.
Treatment duration varies: nail infections may require 6–12 months, while skin infections usually resolve in 2–4 weeks with continued application.
DRUG INTERACTIONS
Amorolfine has minimal systemic absorption, so significant drug interactions are rare. It can generally be used alongside other topical treatments, though strong chemical irritants should be avoided to prevent local irritation. Systemic medications are not affected by amorolfine.
FOOD INTERACTIONS
Amorolfine is applied topically and has negligible systemic absorption, so food has no effect on its efficacy or safety. It can be used without regard to meals.
CONTRAINDICATIONS
Amorolfine is contraindicated in individuals with known hypersensitivity to the drug or any of its components. It should not be applied to damaged, inflamed, or infected skin or nails caused by non-fungal organisms, as it will be ineffective and may cause irritation. Use in children is generally not recommended unless specifically prescribed, due to limited safety data in this population.
SIDE EFFECTS
Generally well tolerated due to minimal systemic absorption.
Local irritation: redness, itching, or burning at the application site.
Allergic reactions: rare, but possible.
Systemic side effects: extremely uncommon.
Discomfort is usually mild and temporary.
TOXICITY
Amorolfine has a low toxicity profile due to its topical use and minimal systemic absorption. Overdose is unlikely when used as directed. High local concentrations may occasionally cause skin or nail irritation, but serious toxic effects are extremely rare. Long-term systemic toxicity has not been reported.
